Abstract:Chemoresistance has been a significant problem affecting the efficacy of drugs targeting tumors for decades. MGMT, known as O-6-methylguanine-DNA methyltransferase, is a DNA repair enzyme that plays an important role in chemoresistance to alkylating agents. Hence, MGMT is considered a promising target for tumor treatment. Several methods are employed to detect MGMT, each with its own advantages and disadvantages. Some of the detection methods are; immunohistochemistry, methylation-specific PCR (MSP), pyrophosphate sequencing, MGMT activity test, and real-time quantitative PCR. Methylation of MGMT promoter is a key predictor of whether alkylating agents can effectively control glioma cells. The prognostic value of MGMT in glioma is currently being explored. The expression of MGMT gene mainly depends on epigenetic modification-methylation of CpG island of MGMT promoter. CpG island covers a length of 762 bp, with 98 CpG sites located at the 5' end of the gene, ranging from 480 to 1,480 nucleotides. The methylation sites and frequencies of CpG islands vary in MGMT-deficient tumor cell lines, xenografts of glioblastoma and in situ glioblastoma. Methylation in some regions of promoter CpG islands is particularly associated with gene expression. The change in the methylation status of the MGMT promoter after chemotherapy, radiotherapy or both is not completely understood, and results from previous studies have been controversial. Several studies have revealed that chemotherapy may enhance MGMT expression in gliomas. This could be through gene induction or selection of high MGMT-expressing cells during chemotherapy. Selective survival of glioma cells with high MGMT expression during alkylating agent therapy may change MGMT status in case of recurrence. Several strategies have been pursued to improve the anti-tumor effects of temozolomide. These include the synthesis of analogs of O-6-meG such as O-6-benzylguanine (O-6-BG) and O-6-(4-bromothenyl) guanine (O-6-BTG), RNAi, and viral proteins. This review describes the regulation of MGMT expression and its role in chemotherapy, especially in glioma. Targeting MGMT seems to be a promising approach to overcome chemoresistance. Further studies exploring new agents targeting MGMT with better curative effect and less toxicity are advocated. We anticipate that these developments will improve the current poor prognosis of glioma patients.

Target-mediated Consecutive Endonuclease Reactions for Specific and Sensitive Homogeneous Fluorescence Assay of O6-methylguanine-DNA Methyltransferase.

Integration of Demethylation-Activated DNAzyme with a Single Quantum Dot Nanosensor for Sensitive Detection of O6-Methylguanine DNA Methyltransferase in Breast Tissues.

Fluorescence Determination of the Activity of O6-methylguanine-DNA Methyltransferase Based on the Activation of Restriction Endonuclease and the Use of Graphene Oxide

Construction of a chemiluminescent biosensor based on enzymatic extension and click chemistry for sensitive measurement of MGMT activity in human breast tissues

A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase

A simple and rapid in vitro assay for identification of direct inhibitors of O6-methylguanine-DNA methyltransferase

A chloromethyl-triazole fluorescent chemosensor for O 6 -methylguanine DNA methyltransferase

A simple and rapid mix-and-read assay for sensitive detection of O<sup>6</sup>-methylguanine DNA methyltransferase

O-6-Methylguanine-Dna Methyltransferase (Mgmt): Challenges And New Opportunities In Glioma Chemotherapy

A simple and rapid mix-and-read assay for sensitive detection of O 6 -methylguanine DNA methyltransferase

Single-ribonucleotide Repair-Mediated Ligation-Dependent Cycling Signal Amplification for Sensitive and Specific Detection of DNA Methyltransferase.

Terminal Deoxynucleotidyl Transferase and Rolling Circle Amplification Induced G-triplex Formation: A Label-free Fluorescent Strategy for DNA Methyltransferase Activity Assay

Novel Electrochemical Immunosensor for O6-methylguanine-DNA Methyltransferase Gene Methylation Based on Graphene Oxide-Magnetic Nanoparticles-Β-cyclodextrin Nanocomposite.

Sensitive Detection of DNA Methyltransferase Using Hairpin Probe-Based Primer Generation Rolling Circle Amplification-Induced Chemiluminescence.

Sensitive Detection of DNA Methyltransferase Activity Based on Supercharged Fluorescent Protein and Template-Free DNA Polymerization

A Dual Amplification Fluorescent Strategy for Sensitive Detection of DNA Methyltransferase Activity Based on Strand Displacement Amplification and DNAzyme Amplification.

Commercial Glucometer As Signal Transducer for Simple Evaluation of DNA Methyltransferase Activity and Inhibitors Screening

A Loop-Mediated Cascade Amplification Strategy for Highly Sensitive Detection of DNA Methyltransferase Activity

A label-free fluorescence sensing strategy based on GlaI-assisted EXPAR for rapid and accurate quantification of human methyltranferase activity

Coupling Hybridization Chain Reaction with DNAzyme Recycling for Enzyme-Free and Dual Amplified Sensitive Fluorescent Detection of Methyltransferase Activity

Fluorescence Turn-off Strategy for Sensitive Detection of DNA Methyltransferase Activity Based on DNA-templated Gold Nanoclusters.